VVP
ONCS

Venture Visionary Partners’s OncoSec Medical Incorporated ONCS Stock Holding History

Venture Visionary Partners’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-68
Closed -$1.11K – 1684
2022
Q2 		$1.11K Buy
+68
New +$1.3K ﹤0.01% 1594

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Venture Visionary Partners's ONCS Position: Q3 2022 in Review

Venture Visionary Partners sold out of OncoSec Medical Incorporated (ONCS) in Q3 2022, closing a stake of 68 shares — an estimated $1.11K sold.

Venture Visionary Partners first reported a position in ONCS in Q2 2022 and held it in 1 quarter. The position peaked at $1.11K in Q2 2022. 23 funds tracked by Wall St. Rank hold ONCS as of Q3 2022.

  • Venture Visionary Partners reported no remaining OncoSec Medical Incorporated position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 68 OncoSec Medical Incorporated shares in Q3 2022, an estimated $1.11K.
  • Venture Visionary Partners first reported a position in OncoSec Medical Incorporated in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's OncoSec Medical Incorporated position peaked at $1.11K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.